UNDIFFERENTIATED SARCOMA

UNDIFFERENTIATED SARCOMA was reported 51 times

UNDIFFERENTIATED SARCOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Actinomycin [EPC] 1 0.0005
1 Iron Chelator [EPC] 3 0.0001
2 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
3 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1 0.0001
4 Alkylating Drug [EPC] 17 0.0001
5 Topoisomerase Inhibitor [EPC] 5 0.0001
6 Non-narcotic Antitussive [EPC] 1 0.0001
7 Antimetabolite Immunosuppressant [EPC] 1 0.0000
8 Calcineurin Inhibitor Immunosuppressant [EPC] 6 0.0000
9 Microtubule Inhibitor [EPC] 6 0.0000
10 Pyridone [EPC] 1 0.0000
11 Parathyroid Hormone Analog [EPC] 2 0.0000
12 Proteasome Inhibitor [EPC] 2 0.0000
13 Calcium [EPC] 2 0.0000
14 Janus Kinase Inhibitor [EPC] 2 0.0000
15 Retinoid [EPC] 3 0.0000
16 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
17 Platinum-based Drug [EPC] 3 0.0000
18 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
19 RANK Ligand Inhibitor [EPC] 2 0.0000
20 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
21 Azole Antifungal [EPC] 1 0.0000
22 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
23 Thalidomide Analog [EPC] 3 0.0000
24 Kinase Inhibitor [EPC] 2 0.0000
25 Platelet Aggregation Inhibitor [EPC] 2 0.0000
26 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
27 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
28 Benzodiazepine [EPC] 2 0.0000
29 Corticosteroid [EPC] 3 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
31 Atypical Antipsychotic [EPC] 1 0.0000
32 Proton Pump Inhibitor [EPC] 1 0.0000
33 Tumor Necrosis Factor Blocker [EPC] 1 0.0000